Literature DB >> 10977228

Pneumatic displacement of submacular hemorrhage.

M W Johnson1.   

Abstract

Patients with thick submacular hemorrhage complicating age-related macular degeneration and other disorders typically have a poor visual prognosis. A new outpatient procedure, consisting of intravitreal injection of tissue plasminogen activator and gas followed by brief prone positioning, is effective in displacing thick submacular blood and facilitating visual improvement in most patients. Injection of gas alone also appears to be effective in many eyes. The procedure is technically simple and the rate of serious complications appears to be acceptably low. Although the final visual outcome is often limited by progression of age-related macular degeneration, significant and stable visual recovery is possible in selected eyes. Prospective clinical trials are needed to clarify the role for intravitreal tissue plasminogen activator and to provide definitive outcome comparisons with other management approaches.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10977228     DOI: 10.1097/00055735-200006000-00009

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  8 in total

1.  Pneumatic release of focal vitreomacular traction.

Authors:  M G Claus; E Feron; M Veckeneer
Journal:  Eye (Lond)       Date:  2016-11-04       Impact factor: 3.775

2.  [Spontaneous macula hemorrhage. Subhyaloid/sub-inner limiting membrane (ILM)].

Authors:  D Völcker; B Junker; L L Hansen
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

3.  Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm.

Authors:  Makoto Inoue; Fumio Shiraga; Yukari Shirakata; Yuki Morizane; Shuhei Kimura; Akito Hirakata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-25       Impact factor: 3.117

4.  [Intravitreal injection. Drugs to treat subretinal hemorrhage].

Authors:  L Hesse
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

5.  Retinal toxicity of intravitreal tenecteplase in the rabbit.

Authors:  S A Rowley; S Vijayasekaran; P K Yu; I L McAllister; D-Yi Yu
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

6.  Pars plana vitrectomy and internal limiting membrane peeling for macular edema secondary to retinal vein occlusion.

Authors:  Nader Baharivand; Amirhossein Hariri; Alireza Javadzadeh; Ebadollah Heidari; Karim Sadegi
Journal:  Clin Ophthalmol       Date:  2011-08-05

7.  Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration.

Authors:  Ramin Nourinia; Mohammad Hossein Jabbarpour Bonyadi; Hamid Ahmadieh
Journal:  J Ophthalmic Vis Res       Date:  2010-07

8.  Risk factors for breakthrough vitreous hemorrhage after intravitreal anti-VEGF injection in age-related macular degeneration with submacular hemorrhage.

Authors:  Yong-Il Shin; Jae-Yun Sung; Min Sagong; Young-Hoon Lee; Young-Joon Jo; Jung-Yeul Kim
Journal:  Sci Rep       Date:  2018-07-12       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.